jetcityimage/iStock Editorial via Getty Images
Update 8.00 AM EST: Adds comments from Seeking Alpha analyst BioCGT Investor
Eli Lilly (NYSE:LLY) on Thursday reported its Q4 2024 results, exceeding Wall Street forecasts and indicating a more than twofold rise in revenue from its weight loss and